A clinical trial on Sivathai chooranam in the management of Vatha gunmam (Peptic ulcer disease)

Phase 2

Not yet recruiting

• Conditions: Health Condition 1: K273- Acute peptic ulcer, site unspecified, without hemorrhage or perforation

• Registration Number: CTRI/2023/05/052505
• Lead Sponsor: Government Siddha Medical College And Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 29 May 2023

Recruitment & Eligibility

• Status: Not Yet Recruiting
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

1.Patients having symptoms with abdominal pain,fatigue and weakness,bodypain,headache,dizziness,polydipsia,xerostomia,constipation,vomiting and indigestion.

2.Patients who are willing to take upper gastrointestinal endoscopy

3. Patients who are willing to give blood specimen for lab investigation when required.

4.Patient willing to sign the informed consent indicating that they understand the purpose and procedures required for the study and are willing to participating the study

Exclusion Criteria

1.Pregnancy

2.Lactating mother

3. Recent malignancy or radiation therapy

4.Gastro esophageal reflux disease

5.Pancreatitis

6.Inflammotary Bowel Disease

7.Acute hepatitis

8.Patients considered unreliable by the investigator (e.g: drug addiction,

Alcohol abuse)

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The outcome is the reduction in clinical symptoms of abdominal pain, fatigue and weakness, body pain,headache,dizziness ,polydipsia,xerostomia, constipation, vomiting and indigestionTimepoint: 45 days

Secondary Outcome Measures

Name	Time	Method
The secondary outcome will be the evaluation of siddha diagnostic parameters assessment of safety profile of trial drug assesment of pharmacological and biochemical parameters of the trial drugTimepoint: 45 days